Percutaneous Decannulation of Extracorporeal Membrane Oxygenation Using MANTA Vascular Closure Device

Not Applicable

Recruiting

• Conditions: Extracorporeal Membrane Oxygenation; Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12621000791831
• Lead Sponsor: Antony Walton

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-06-23
• Last Update Posted: 5 June 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Deemed appropriate by the multi-disciplinary team discussion including ICU physician, cardiothoracic surgeon, vascular surgeon, and interventional cardiologist.
-Suitable vascular anatomy as established by vascular ultrasound.
-Suitable body habitus (body mass index >20kg/m2 and <40 kg/m2).

Exclusion Criteria

-Non femoral ECMO.
-Thrombus in CFA/SFA .
-Track depth on ultrasound exceeding 7cm.
-Puncture site of arterial cannula close to bifurcation , or other unfavourable features such as heavily calcified CFA.
-Arterial re-cannulation cases.
-ECMO > 14 days in situ.
-Known bleeding disorder including thrombocytopenia (platelet count <50 000 cells/µL), thrombasthenia, haemophilia, von Willebrand disease.
-Cannula site infection.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Puncture closure without the use of surgical or additional endovascular intervention<br><br>Assessment: Trial team notification by the multidisciplinary medical team, patient medical records.[72 hours]